Clinical Trial Update: Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating venetoclax with azacitidine for newly diagnosed higher-risk myelodysplastic syndrome. The study is currently active but not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Venetoclax (venetoclax)

Snippet

Sponsor: AbbVie | Conditions: Myelodysplastic Syndrome (MDS) | Phase 3 | Status: ACTIVE_NOT_RECRUITING